Soy protein reduces hepatic lipotoxicity in hyperinsulinemic obese Zucker fa/fa rats Published, JLR Papers in Press, July 1, 2005. DOI 10.1194/jlr.M500067-JLR200
Soy protein reduces hepatic lipotoxicity in hyperinsulinemic obese Zucker fa/fa rats Published, JLR Papers in Press, July 1, 2005. DOI 10.1194/jlr.M500067-JLR200
复制标题
大豆蛋白降低高胰岛素肥胖 Zucker fa/fa 大鼠的肝脂毒性 出版,JLR Papers in Press,2005 年 7 月 1 日。DOI 10.1194/jlr.M500067-JLR200
DOI:
10.1194/jlr.m500067-jlr200
复制
发表时间:
2005
影响因子:
6.5
通讯作者:
N. Torres
中科院分区:
文献类型:
--
作者:
A. Tovar;Iván Torre;Melissa K. Ochoa;A. Elias;V. Ortíz;C. Aguilar;N. Torres
Hepatic steatosis is commonly present during the development of insulin resistance, and it is a clear sign of lipotoxicity attributable in part to an accelerated lipogenesis. There is evidence that a soy protein diet prevents the overexpression of hepatic sterol-regulatory element binding protein-1 (SREBP-1), decreasing lipid accumulation. Therefore, the aim of the present work was to study whether a soy protein diet may prevent the development of fatty liver through the regulation of transcription factors involved in lipid metabolism in hyperinsulinemic and hyperleptinemic Zucker obese fa/fa rats. Serum and hepatic cholesterol and triglyceride levels, as well as VLDL-triglyceride and LDL-cholesterol, were significantly lower in rats fed soy protein than in rats fed a casein diet for 160 days. The reduction in hepatic cholesterol was associated with a low expression of liver X receptor-α and its target genes, 7-α hydroxylase and ABCA1. Soy protein also decreased the expression of SREBP-1 and several of its target genes, FAS, stearoyl-CoA desaturase-1, and Δ5 and Δ6 desaturases, decreasing lipogenesis even in the presence of hyperinsulinemia. Reduction in SREBP-1 was not associated with the presence of soy isoflavones. Finally, soy protein reduced SREBP-1 expression in adipocytes, preventing hypertrophy, which also helps prevent the development of hepatic lipotoxicity.
登录
查看更多内容
DOI:
--
发表时间:
2002
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
J. Repa;K. Berge;Chris Pomajzl;J. Richardson;H. Hobbs;D. Mangelsdorf
通讯作者:
J. Repa;K. Berge;Chris Pomajzl;J. Richardson;H. Hobbs;D. Mangelsdorf
DOI:
10.1172/jci15593
发表时间:
2002-05
期刊:
The Journal of clinical investigation
影响因子:
--
作者:
J. Horton;J. Goldstein;Michael S. Brown
通讯作者:
J. Horton;J. Goldstein;Michael S. Brown
影响因子:
15.9
作者:
Shimano, H;Horton, JD;Goldstein, JL
通讯作者:
Goldstein, JL
DOI:
10.1172/jci22422
发表时间:
2004-07
期刊:
The Journal of clinical investigation
影响因子:
--
作者:
J. Browning;J. Horton
通讯作者:
J. Browning;J. Horton
影响因子:
56.9
作者:
Repa, JJ;Turley, SD;Mangelsdorf, DJ
通讯作者:
Mangelsdorf, DJ